Should New HEPZATO Subgroup Data and Delcath’s Targeted Strategy Require Action From DCTH Investors?

Delcath Systems announced that subgroup analyses from its phase 3 FOCUS study of the FDA-approved HEPZATO KIT for unresectable metastatic uveal melanoma were published in the Journal of Cancer ...

Delcath Systems Announces Publication of Subgroup Analyses of the Phase 3 FOCUS Study of Melphalan/Hepatic Delivery System in Patients with Unresectable Metastati…

Delcath Systems, Inc. (Nasdaq: DCTH), ("Delcath" or the "Company") an interventional oncology company focused on the ...
Business Wire

New subgroup analyses of CLEAR Outcomes data showed bempedoic acid reduced the risk of major adverse cardiovascular events across various patient groups

These subgroup analyses add to the existing evidence of bempedoic acid as an effective treatment for the reduction of cardiovascular risk. MUNICH--(BUSINESS WIRE)--Daiichi Sankyo Europe GmbH ...
Houston Chronicle

How LinkedIn Subgroups Work

You can find over one million groups to join on LinkedIn, the social media network for professionals. Topics vary from discussions about how to think creatively to learning something new such as ...
Time

Rep. Steve King Asks What ‘Subgroup’ Contributed More to Civilization Than Whites

Rep. Steve King (R-Iowa) sparked anger on Monday by asking about which “subgroup” had contributed more to advancements in civilization than white people. While participating in an MSNBC panel hosted ...
Los Angeles Times

Oversight officials concerned about Nazi symbolism in newly discovered deputy subgroup’s logo

The Civilian Oversight Commission is raising concerns about a previously unknown deputy subgroup that oversight officials say uses a logo featuring Nazi-like imagery, according to a memo obtained by ...
Morningstar

Delcath Systems Announces Publication of Subgroup Analyses of the Phase 3 FOCUS Study of Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma

Delcath Systems Announces Publication of Subgroup Analyses of the Phase 3 FOCUS Study of Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma Delcath Systems, Inc.